[1]张学森,王 瑞,伍鼎建.小剂量右美托咪定联合经鼻高流量氧疗治疗急性心力衰竭的临床疗效[J].医学信息,2022,35(13):100-102.[doi:10.3969/j.issn.1006-1959.2022.13.022]
　ZHANG Xue-sen,Wang Rui,WU Ding-jian.Clinical Efficacy of Low-dose Dexmedetomidine Combined with Transnasal High-flow Oxygen Therapy in Patients with Acute Heart Failure[J].Medical Information,2022,35(13):100-102.[doi:10.3969/j.issn.1006-1959.2022.13.022]
点击复制

小剂量右美托咪定联合经鼻高流量氧疗治疗急性心力衰竭的临床疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年13期
页码:
100-102
栏目:
论著
出版日期:
2022-07-01

文章信息/Info

Title:
Clinical Efficacy of Low-dose Dexmedetomidine Combined with Transnasal High-flow Oxygen Therapy in Patients with Acute Heart Failure
文章编号:
1006-1959（2022）13-0100-03
作者:
张学森; 王 瑞; 伍鼎建
（联勤保障部队第九四五医院心肾内科，四川 雅安 622500）
Author(s):
ZHANG Xue-sen; Wang Rui; WU Ding-jian
(Department of Cardiology and Nephrology,945th Hospital of the PLA Joint Logistics Support Force,Ya’an 622500,Sichuan,China)
关键词:
右美托咪定; 急性左心衰; 经鼻高流量氧疗
Keywords:
Dexmedetomidine; Acute left heart failure; Transnasal high flow oxygen therapy
分类号:
R541.6
DOI:
10.3969/j.issn.1006-1959.2022.13.022
文献标志码:
A
摘要:
目的 研究小剂量右美托咪定联合经鼻高流量氧疗（HFNC）治疗急性左心衰的临床疗效。方法 选取2019年9月-2020年10月我院接诊的130例急性心力衰竭患者为研究对象，采用随机数字表法分为对照组和观察组，各65例。对照组采用经鼻高流量氧疗治疗，观察组在对照组基础上给予小剂量右美托咪定。比较两组临床治疗呼吸和心功能指标、血气指标、治疗疗效、HFNC时间、气管插管和谵妄以及病死率。结果 两组心率（HR）、呼吸频率（RR）均低于治疗前，左室射血分数（LVEF）大于治疗前，且观察组HR、RR均低于对照组，LVEF大于对照组（P＜0.05）；治疗后，血氧饱和度（SpO2）、动脉血氧分压（PaO2）均高于治疗前，二氧化碳分压（PCO2）均小于治疗前，且观察组SpO2、PaO2大于对照组，PCO2小于对照组（P＜0.05）；观察组治疗总有效率为95.38%，高于对照组的81.53%（P＜0.05）；观察组HFNC时间短于对照组，气管插管、谵妄发生率均小于对照组（P＜0.05）；两组病死率比较，差异无统计学意义（P＞0.05）。结论 小剂量右美托咪定联合经鼻高流量氧疗治疗急性心力衰竭效果确切，可提高治疗疗效，显著改善呼吸和心功能指标，提高血氧饱和度，改善呼吸困难状况，降低气管插管和谵妄率，缩短HFNC时间，且不会增加病死率，具有相对良好的有效性和安全性。
Abstract:
Objective To study the clinical efficacy of low-dose dexmedetomidine combined with transnasal high flow oxygen therapy (HFNC) in the treatment of acute left heart failure.Methods A total of 130 patients with acute heart failure admitted to our hospital from September 2019 to October 2020 were selected as the research objects. They were divided into control group and observation group by random number table method, with 65 cases in each group. The control group was treated with ransnasal high flow oxygen therapy, and the observation group was given low-dose dexmedetomidine on the basis of the control group. The respiratory and cardiac function indexes, blood gas indexes, therapeutic efficacy, HFNC time, tracheal intubation, delirium and mortality in the two groups were compared.Results The heart rate (HR) and respiratory rate (RR) of the two groups were lower than those before treatment, and the left ventricular ejection fraction (LVEF) was higher than that before treatment, while the HR and RR of the observation group were lower than those of the control group, and the LVEF was higher than that of the control group (P＜0.05). After treatment, the blood oxygen saturation (SpO2) and arterial oxygen partial pressure (PaO2) of the two groups were higher than those before treatment, and the carbon dioxide partial pressure (PCO2) was lower than that before treatment, while the SpO2 and PaO2 of the observation group were higher than those of the control group, and the PCO2 was lower than that of the control group (P＜0.05). The total effective rate of the observation group was 95.38%, which was higher than 81.53% of the control group (P＜0.05). The HFNC time of the observation group was shorter than that of the control group, and the incidence of tracheal intubation and delirium was lower than that of the control group (P＜0.05); there was no significant difference in mortality between the two groups (P>0.05).Conclusion Low-dose dexmedetomidine combined with transnasal high flow oxygen therapy is effective in the treatment of acute heart failure, which can improve the therapeutic effect, significantly improve respiratory and cardiac function indexes, increase blood oxygen saturation, improve dyspnea, reduce tracheal intubation and delirium rate, shorten HFNC time, and do not increase mortality, with relatively good efficacy and safety.

参考文献/References:

[1]薛翔,贾凌,杨敬辉,等.经鼻高流量氧疗与无创通气治疗急性左心衰竭的效果比较[J].中国急救复苏与灾害医学杂志,2020,159(1):42-45[2]黄传斌.静脉滴注左卡尼汀治疗急性心力衰竭的临床疗效[J].山西医药杂志,2020,49(16):2169-2171.[3]中国医师协会急诊医师分会,中国心胸血管麻醉学会急救与复苏分会,中国急性心力衰竭急诊临床实践指南(2017)[J].中华急诊医学杂志,2017,6(12):1347-1357.[4]Nishimura M.High-flow nasal cannula oxygen therapy in adults: physiological benefits, Indication,clinical benefits, and adverse effects[J].Respir Care,2016,61(4):529-541.[5]王擂,潘文静,尚文礼,等.右美托咪定在急性左心衰患者中的应用研究[J].中国急救复苏与灾害医学杂志,2018(10):949-951.[6]陈兆芸,彭文宏,马君武.小剂量右美托咪定对老年急性左心力衰竭患者无创正压通气的影响[J].中国药物经济学,2018,13(12):47-50.[7]王贵强,袁灵,杨盛泉,等.右美托咪定在急性左心衰治疗应用中的疗效和安全性探讨[J].临床药物治疗杂志,2018,16(3):33-36.[8]陈辰,胡松.盐酸曲美他嗪联合米力农治疗老年心衰患者的临床疗效研究[J].新疆医科大学学报,2019,42(7):883-886.[9]李明臣.增强型体外反搏联合麝香保心丸治疗急性心肌梗死伴左心衰疗效观察[J].现代中西医结合杂志,2017,26(16):1807-1809.[10]谢胜,王国标.双水平气道正压无创通气辅助治疗急性左心衰竭并低氧血症的临床效果[J].实用心脑肺血管病杂志,2017,25(6):85-88.[11]张日霖,陈淑玲,李庆军,等.右美托咪定在无创正压机械通气治疗急性左心衰竭中的应用[J].广东医科大学学报,2018(4):473-475.[12]刘闵育,周炳凤,王举红,等.无创呼吸机压力支持在急性心源性肺水肿急救中的疗效[J].中国循证心血管医学杂志,2021,13(9):1058-1062,1067.[13]董双虎,何青云,龚志翔,等.经鼻高流量氧疗治疗急性低氧性呼吸衰竭的疗效[J].实用临床医学,2018,19(4):4-6.[14]安勇鹏,罗松平,杨秀芝.经鼻高流量氧疗治疗心源性肺水肿的疗效观察[J].临床急诊杂志,2018,19(11):762-764.[15]朱晓飞,苏秀平,王丁超.无创呼吸机在ICU急性心衰合并呼吸衰竭患者治疗中的应用效果[J].黑龙江医药,2019,32(2):407-408.[16]王晓玲,李宝红,尉家森,等.经鼻高流量氧疗对急性呼吸衰竭患者血气分析结果和血流动力学的影响[J].内科,2019,14(5):529-531,611[17]张珂,田凤娥,刘景刚.经鼻高流量氧疗在急性心力衰竭治疗中的临床应用[J].中国基层医药,2019,26(5):527-531.[18]韩秋颖,冼少芳,余健,等.经鼻高流量氧疗在急性心力衰竭伴低氧血症患者中的应用[J].新疆医科大学学报,2020,43(5):620-623,628.[19]赵猛,孔令贵,吴霞,等.右美托咪定治疗老年急性左心衰竭合并Ⅰ型呼吸衰竭的临床研究[J].中国中西医结合急救杂志,2020,27(6):679-681.

相似文献/References:

[1]杨进斌,韩建阁.右美托咪定复合丙泊酚和芬太尼在无痛人流术中的应用观察[J].医学信息,2018,31(03):134.[doi:10.3969/j.issn.1006-1959.2018.03.047]
　YANG Jin-bin,HAN Jian-ge.Application of Dexmetomidine Combined with Propofol and Fentanyl in Painless Induced Abortion[J].Medical Information,2018,31(13):134.[doi:10.3969/j.issn.1006-1959.2018.03.047]
[2]侯 江.舒芬太尼联合右美托咪定用于临床麻醉的效果观察[J].医学信息,2018,31(03):144.[doi:10.3969/j.issn.1006-1959.2018.03.051]
　HOU Jiang.Clinical Observation on the Effect of Sufendate Combined with Dexlansoprazole in Clinical Anesthesia[J].Medical Information,2018,31(13):144.[doi:10.3969/j.issn.1006-1959.2018.03.051]
[3]陶 晶,王 鑫,黄 擘,等.右美托咪定对截肢术后发生谵妄的疗效观察[J].医学信息,2018,31(04):123.[doi:10.3969/j.issn.1006-1959.2018.04.043]
　TAO Jing,WANG Xin,HUANG Bo,et al.Therapeutic Effect of Dexmedetomidine on Delirium after Amputation[J].Medical Information,2018,31(13):123.[doi:10.3969/j.issn.1006-1959.2018.04.043]
[4]江亚楠,梁永新,施彩凤,等.右美托咪定在大鼠脊髓缺血再灌注损伤中的 保护作用及机制研究[J].医学信息,2018,31(07):69.[doi:10.3969/j.issn.1006-1959.2018.07.022]
　JIANG Ya-nan,LIANG Yong-xin,SHI Cai-feng,et al.Protective Effects and Mechanism of Dexmedetomidine on Spinal Cord Ischemia-Reperfusion Injury in Rats[J].Medical Information,2018,31(13):69.[doi:10.3969/j.issn.1006-1959.2018.07.022]
[5]孙素花,宋建防,褚海辰,等.右美托咪定经鼻给药在胸腔镜肺叶切除术中的疗效观察[J].医学信息,2018,31(07):78.[doi:10.3969/j.issn.1006-1959.2018.07.025]
　SUN Su-hua,SONG Jian-fang,CHU Hai-chen,et al.Efficacy of Dexmetomidine in Thoracoscopic Lobectomy by Nasal Administration[J].Medical Information,2018,31(13):78.[doi:10.3969/j.issn.1006-1959.2018.07.025]
[6]王绪飞,梁永新.右美托咪定复合布比卡因骶管阻滞对预防七氟醚 小儿麻醉苏醒期躁动的观察分析[J].医学信息,2018,31(08):78.[doi:10.3969/j.issn.1006-1959.2018.08.024]
　WANG Xu-fei,LIANG Yong-xin.Observation of Dexmedetomidine Combined with Bupivacaine Caudal Block in Preventing Sedation in Children with Sevoflurane during Anesthesia Recovery Period[J].Medical Information,2018,31(13):78.[doi:10.3969/j.issn.1006-1959.2018.08.024]
[7]李 璟,蒋 娜,王晶晶,等.右美托咪定对H9C2心肌细胞缺氧/复氧损伤的保护作用[J].医学信息,2018,31(09):83.[doi:10.3969/j.issn.1006-1959.2018.09.025]
　LI Jing,JIANG Na,WANG Jing-jing,et al.Protective Effects of Dexmedetomidine on Hypoxia/Reoxygenation Injury in H9C2 Cardiomyocytes[J].Medical Information,2018,31(13):83.[doi:10.3969/j.issn.1006-1959.2018.09.025]
[8]赵 亮,王绍林.右美托咪定滴鼻和七氟烷吸入对患儿麻醉前镇静和 苏醒后躁动的影响[J].医学信息,2018,31(10):124.[doi:10.3969/j.issn.1006-1959.2018.10.040]
　ZHAO Liang,WANG Shao-lin.Effects of Dexmedetomidine Dripping and Seven Halothane Inhalation on Sedation and Recovery Agitation after Anesthesia in Children[J].Medical Information,2018,31(13):124.[doi:10.3969/j.issn.1006-1959.2018.10.040]
[9]疏 腾,胡胜红,叶 慧,等.静脉输注右美托咪定对甲状腺切除手术患者术后恢复质量的影响[J].医学信息,2022,35(09):161.[doi:10.3969/j.issn.1006-1959.2022.09.041]
　SHU Teng,HU Sheng-hong,YE Hui,et al.Effect of Intravenous Infusion of Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thyroid Surgery[J].Medical Information,2022,35(13):161.[doi:10.3969/j.issn.1006-1959.2022.09.041]
[10]程 燕,张 宁,郭金光.右美托咪定替代瑞芬太尼对甲状腺手术 全麻患者术后恶心呕吐的影响[J].医学信息,2018,31(12):83.[doi:10.3969/j.issn.1006-1959.2018.12.025]
　CHENG Yan,ZHANGN Ning,GUO Jin-guang.Effect of Dexmedetomidine in Place of Remifentanil on Postoperative Nausea and Vomiting in General Anesthesia Patients Undergoing Thyroid Surgery[J].Medical Information,2018,31(13):83.[doi:10.3969/j.issn.1006-1959.2018.12.025]

更新日期/Last Update: 1900-01-01